Lacerta Therapeutics

OverviewSuggest Edit

Lacerta Therapeutics is focused on CNS-targeted treatments and lysosomal storage diseases. It is a clinical stage gene therapy company using a constellation of proprietary adeno-associated virus (AAV) vector technologies to develop treatments for central nervous system and lysosomal storage diseases.

TypePrivate
Founded2017
HQAlachua, FL, US
Websitelacertatx.com

Latest Updates

Employees (est.) (Apr 2022)46(-2%)
Cybersecurity ratingAMore
Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
Banner background

Key People/Management at Lacerta Therapeutics

Edgar Rodriguez

Edgar Rodriguez

Chairman and President
Shyam Gajavelli

Shyam Gajavelli

Director, Pre-Clinical Technology
Joseph Zenkus

Joseph Zenkus

Director
Show more

Lacerta Therapeutics Office Locations

Lacerta Therapeutics has an office in Alachua
Alachua, FL, US (HQ)
12085 Research Dr #46Alachua
Alachua, FL, US
N W 129th Way
Show all (2)

Lacerta Therapeutics Financials and Metrics

Summary Metrics

Founding Date

2017

Lacerta Therapeutics total Funding

$30 m

Lacerta Therapeutics latest funding size

$30 m

Time since last funding

4 years ago

Lacerta Therapeutics investors

Lacerta Therapeutics's latest funding round in August 2018 was reported to be $30 m. In total, Lacerta Therapeutics has raised $30 m
Show all financial metrics

Lacerta Therapeutics Cybersecurity Score

Cybersecurity ratingPremium dataset

A

93/100

SecurityScorecard logo

Lacerta Therapeutics Online and Social Media Presence

Embed Graph

Lacerta Therapeutics News and Updates

Lacerta Therapeutics Blogs

Lacerta Therapeutics Expands Executive Leadership Team

ALACHUA, Fla.–(BUSINESS WIRE)–Lacerta Therapeutics, a preclinical-stage gene therapy company, announces an expansion in the executive leadership team: Kenneth Warrington, Jr., PhD, co-founder of Lacerta, has joined as the company’s Chief Technology Officer (CTO), and Darin Falk, PhD, former Vice Pre…

GrowFL Announces Lacerta Therapeutics as an Honoree: 11th Annual Florida Companies to Watch

ALACHUA, Fla.–(BUSINESS WIRE)–Lacerta Therapeutics is pleased to be among the top 50 second-stage companies in Florida selected as an 11th Annual GrowFL Florida Companies to Watch honoree, a statewide competition that identifies companies expected to see significant growth over the next several year…

Lacerta Therapeutics Appoints Min Wang, PhD, JD and Marc Wolff to its Board of Directors

ALACHUA, Fla.–(BUSINESS WIRE)–Lacerta Therapeutics, Inc. a gene therapy company dedicated to the discovery and development of AAV-based gene therapies, appoints Min Wang, PhD, JD and Marc Wolff to its Board of Directors. Dr. Min Wang has over 20 years of experience in the biotech space where she has…

LACERTA THERAPEUTICS FEATURED AT ALACHUA CHAMBER LUNCH

We want to thank the Alachua Chamber of Commerce for featuring us at the Alachua Chamber Lunch on August 3rd, 2021 at the Alachua Woman’s Club! Dr. Edgar Rodriguez-Lebron and Dr. Jackson Streeter presented a well-rounded introduction of our company and upcoming biotechnology endeavors. We look forwa…

UCB is beefing up its gene therapy ops with back-to-back deals to buy a startup and sign up a university spinout for discovery work

The post UCB is beefing up its gene therapy ops with back-to-back deals to buy a startup and sign up a university spinout for discovery work appeared first on Lacerta Therapeutics.

UCB strengthens its gene therapy activities with additional pipeline programs, capabilities and platforms

The post UCB strengthens its gene therapy activities with additional pipeline programs, capabilities and platforms appeared first on Lacerta Therapeutics.
Show more

Lacerta Therapeutics Frequently Asked Questions

  • When was Lacerta Therapeutics founded?

    Lacerta Therapeutics was founded in 2017.

  • Who are Lacerta Therapeutics key executives?

    Lacerta Therapeutics's key executives are Edgar Rodriguez, Shyam Gajavelli and Joseph Zenkus.

  • How many employees does Lacerta Therapeutics have?

    Lacerta Therapeutics has 46 employees.

  • Who are Lacerta Therapeutics competitors?

    Competitors of Lacerta Therapeutics include Taysha Gene Therapies, Passage Bio and Gyroscope Therapeutics.

  • Where is Lacerta Therapeutics headquarters?

    Lacerta Therapeutics headquarters is located at 12085 Research Dr #46Alachua, Alachua.

  • Where are Lacerta Therapeutics offices?

    Lacerta Therapeutics has an office in Alachua.

  • How many offices does Lacerta Therapeutics have?

    Lacerta Therapeutics has 2 offices.